Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
(NASDAQ: DARE) Delayed: 0.81 +0.03 (3.85%)
Previous Close $0.78    52 Week High $ 
Open $0.82    52 Week Low $ 
Day High $0.84    P/E N/A 
Day Low $0.80    EPS $ 
Volume 279,935       

(NASDAQ: DARE) Delayed: 0.81 +0.03 (3.85%)
Previous Close $0.78    52 Week High $ 
Open $0.82    52 Week Low $ 
Day High $0.84    P/E N/A 
Day Low $0.80    EPS $ 
Volume 279,935